Secukinumab improves mild-to-moderate psoriasis: A randomized, placebo-controlled exploratory clinical trial. Academic Article uri icon

Overview

publication date

  • May 9, 2022

Research

keywords

  • Antibodies, Monoclonal, Humanized
  • Psoriasis

Identity

Scopus Document Identifier

  • 85130894365

Digital Object Identifier (DOI)

  • 10.1016/j.jaad.2022.04.060

PubMed ID

  • 35551962

Additional Document Info

volume

  • 88

issue

  • 2